APN News

  • Thursday, April, 2024| Today's Market | Current Time: 10:05:40
  • Novotech COVID-19 Clinical Trial Clients Benefit from New Asia-Pacific Fast-Track Review Processes

    Published on April 28, 2020

    SYDNEY: Asia-Pacific’s largest specialist biotech CRO Novotech said many countries in the region were now fast-tracking their COVID-19 clients’ clinical trials with expedited review processes for treatment and vaccine candidates.

    A Novotech Client COVID-19 trial was just approved in under 9 days in South Korea.

    The South Korean Ministry of Food and Drug Safety (MFDS) has announced “GO-expedite” program where they are expediting the review process for COVID-19 treatment and vaccine trials with specific timelines.

    Other countries are also fast-tracking COVID-19 trial reviews including:
    — India: review/approval in 10 working days
    — Thailand: review/approval in 15 working days
    — Malaysia: review/approval in 20 working days

    Novotech Executive Director, Asia Operations, Dr. Yooni Kim said she was pleased to see such a rapid response in the region to support vital research.

    “We are seeing an increase in demand from biotechnology sponsors for studies in the Asia-Pacific region because of the speed and quality available here. This expedited review process will further support the race for COVID-19 treatments.”

    SEE COMMENTS

    Leave a Reply